Elsevier

Joint Bone Spine

Volume 83, Issue 6, December 2016, Pages 739-740
Joint Bone Spine

Letter to the Editor
Rheumatoid arthritis and antisynthetase syndrome. A three cases report

https://doi.org/10.1016/j.jbspin.2015.10.014Get rights and content

Section snippets

Disclosure of interest

The authors declare that they have no competing interest.

References (10)

  • L. Iaccarino et al.

    Overlap connective tissue disease syndromes

    Autoimmun Rev

    (2013)
  • G.E. Mumm et al.

    Antisynthetase syndrome presenting as rheumatoid-like polyarthritis

    J Clin Rheumatol

    (2010)
  • G. Lefèvre et al.

    Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients

    Rheumatology (Oxford)

    (2015)
  • M. Labrador-Horrillo et al.

    Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy

    Rheumatology (Oxford)

    (2009)
  • O. Meyer et al.

    Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome

    Ann Rheum Dis

    (2009)
There are more references available in the full text version of this article.

Cited by (4)

  • Autoantibodies to extractable nuclear antigens (ENAs) pattern in rheumatoid arthritis patients: Relevance and clinical implications

    2021, Reumatologia Clinica
    Citation Excerpt :

    The latter finding was supported by those of Aggarwal et al.38 who pointed out that ILD can be associated with ASS related autoantibodies, even in the absence of clinically apparent AIM. Although RA and ASS are distinct clinical syndromes, their co-occurrence may be rarely encountered and by early diagnosis serious or even fatal ILD can be prevented by early and appropriate treatment.5–10 A limitation of our study is that many studies were done regarding ENA autoantibodies including ANA, anti-Ro and anti-La in relation to secondary Sjogren's syndrome.

View full text